secwatch.observer — SEC 8-K summary
======================================

Issuer:     TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK:        0001630627
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0000950170-25-004578
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Treace Medical preliminary Q4 rev ~$68.6M, FY2024 ~$209.2M, up 12% YoY
----------------------------------------------------------------------

- Preliminary Q4 revenue $68.4M-$68.8M, ~10% increase at midpoint vs Q4 2023.
- Full-year 2024 revenue $209.0M-$209.4M, ~12% growth at midpoint, in line with $204M-$211M guidance.
- Added ~280 active surgeons in 2024; total ~3,135 active surgeons (+10% YoY), ~31% of US bunion surgeon market.
- 2025 financial guidance to be provided during Q4 2024 earnings call on Feb 27, 2025.
- Management to present at J.P. Morgan Healthcare Conference on Jan 14, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630627/000095017025004578/0000950170-25-004578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630627/000095017025004578/tmci-20250113.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-004578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer